Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-05 Sale | 2025-03-07 5:12 pm | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 50,000 | $11.21 | $560,446 | 408,074 (Direct) | View |
| 2025-02-03 Sale | 2025-02-04 4:35 pm | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 50,000 | $12.31 | $615,565 | 334,410 (Direct) | View |
| 2025-01-06 Sale | 2025-01-07 6:24 pm | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 50,000 | $11.1 | $555,065 | 219,410 (Direct) | View |
| 2024-12-17 Sale | 2024-12-19 4:20 pm | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 100,000 | $11.67 | $1,167,100 | 10,105,694 (Indirect Direct) | View |
| 2024-12-17 Sale | 2024-12-19 4:20 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 100,000 | $11.67 | $1,167,100 | 10,105,694 (Indirect Direct) | View |
| 2024-12-12 Sale | 2024-12-13 7:53 pm | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 144,605 | $12.23 | $1,768,093 | 310,888 (Direct) | View |
| 2024-12-11 Sale | 2024-12-13 7:52 pm | ARS Pharmaceuticals Inc. | SPRY | Dorsey Brian Chief Operating Officer | 40,000 | $12.35 | $493,859 | 74,680 (Direct) | View |
| 2024-12-10 Sale | 2024-12-12 5:41 pm | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 50,000 | $13.15 | $657,625 | 136,380 (Direct) | View |
| 2024-12-10 Sale | 2024-12-11 6:30 pm | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 100,000 | $13.16 | $1,316,420 | 10,256,647 (Indirect Direct) | View |
| 2024-12-10 Sale | 2024-12-11 6:30 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 100,000 | $13.16 | $1,316,420 | 10,256,647 (Indirect Direct) | View |
| 2024-12-04 Sale | 2024-12-06 7:15 pm | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 144,640 | $14.11 | $2,041,200 | 436,020 (Direct) | View |
| 2024-12-02 Sale | 2024-12-04 9:45 pm | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 90,000 | $13.43 | $1,208,619 | 334,280 (Direct) | View |
| 2024-12-02 Sale | 2024-12-04 9:40 pm | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 200,000 | $13.44 | $2,688,751 | 368,852 (Direct) | View |
| 2024-12-02 Sale | 2024-12-04 9:40 pm | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 10,000 | $14.04 | $140,423 | 1,181,152 (Direct) | View |
| 2024-11-25 Sale | 2024-11-27 4:11 pm | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 100,000 | $14.12 | $1,411,742 | 136,380 (Direct) | View |
| 2024-11-19 Sale | 2024-11-21 4:30 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 100,000 | $13.95 | $1,394,960 | 10,218,153 (Indirect Direct) | View |
| 2024-11-19 Sale | 2024-11-21 4:30 pm | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 100,000 | $13.95 | $1,394,960 | 10,218,153 (Indirect Direct) | View |
| 2024-11-12 Sale | 2024-11-14 4:30 pm | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 100,000 | $16.85 | $1,684,642 | 10,369,106 (Indirect Direct) | View |
| 2024-11-12 Sale | 2024-11-14 4:30 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 100,000 | $16.85 | $1,684,642 | 10,369,106 (Indirect Direct) | View |
| 2024-11-11 Sale | 2024-11-13 8:16 pm | ARS Pharmaceuticals Inc. | SPRY | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. 10% Owner | 563,270 | $18.01 | $10,143,706 | 5,257,328 (Indirect) | View |
| 2024-10-16 Sale | 2024-10-17 4:30 pm | ARS Pharmaceuticals Inc. | SPRY | Scott Kathleen D. Chief Financial Officer | 12,500 | $16 | $200,000 | 815,529 (Indirect Direct) | View |
| 2024-10-15 Sale | 2024-10-17 4:30 pm | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 100,000 | $14.88 | $1,487,595 | 10,368,153 (Indirect Direct) | View |
| 2024-10-15 Sale | 2024-10-17 4:30 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 100,000 | $14.88 | $1,487,595 | 10,368,153 (Indirect Direct) | View |
| 2024-10-08 Sale | 2024-10-10 4:28 pm | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 100,000 | $13.83 | $1,382,775 | 10,519,106 (Indirect Direct) | View |
| 2024-10-08 Sale | 2024-10-10 4:27 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 100,000 | $13.83 | $1,382,775 | 10,519,106 (Indirect Direct) | View |
| 2024-09-18 Sale | 2024-09-19 4:30 pm | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 10,000 | $14 | $140,000 | 600,281 (Direct) | View |
| 2024-09-17 Sale | 2024-09-19 4:29 pm | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 100,000 | $12.93 | $1,293,205 | 10,518,153 (Indirect Direct) | View |
| 2024-09-17 Sale | 2024-09-19 4:26 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 100,000 | $12.93 | $1,293,205 | 10,518,153 (Indirect Direct) | View |
| 2024-09-10 Sale | 2024-09-12 4:25 pm | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 100,000 | $11.5 | $1,149,775 | 10,669,106 (Indirect Direct) | View |
| 2024-09-10 Sale | 2024-09-12 4:24 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 100,000 | $11.5 | $1,149,775 | 10,669,106 (Indirect Direct) | View |
| 2024-08-26 Sale | 2024-08-28 4:30 pm | ARS Pharmaceuticals Inc. | SPRY | Thompson Peter A. Director | 83,695 | $13 | $1,088,035 | 8,288,510 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-05 Exercise | 2025-03-07 5:12 pm | N/A 2032-01-31 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 50,000 | $0 | 408,074 (Direct) | View |
| 2025-03-05 Exercise | 2025-03-07 5:12 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 50,000 | $4.85 | 408,074 (Direct) | View |
| 2025-02-03 Exercise | 2025-02-04 4:35 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 9,064 | $3.15 | 334,410 (Direct) | View |
| 2025-02-03 Exercise | 2025-02-04 4:35 pm | N/A 2032-05-01 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 50,000 | $0 | 334,410 (Direct) | View |
| 2025-02-03 Exercise | 2025-02-04 4:35 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 40,936 | $4.85 | 334,410 (Direct) | View |
| 2025-01-06 Exercise | 2025-01-07 6:24 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 50,000 | $3.15 | 219,410 (Direct) | View |
| 2025-01-06 Exercise | 2025-01-07 6:24 pm | N/A 2032-05-01 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 50,000 | $0 | 219,410 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:30 pm | N/A 2035-01-01 | ARS Pharmaceuticals Inc. | SPRY | Fitzpatrick Alexander A Chief Legal Officer | 152,300 | $0 | 152,300 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:30 pm | N/A 2035-01-01 | ARS Pharmaceuticals Inc. | SPRY | Dorsey Brian Chief Operating Officer | 261,900 | $0 | 261,900 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:30 pm | N/A 2035-01-01 | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 1,029,500 | $0 | 1,029,500 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:30 pm | N/A 2035-01-01 | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 1,029,500 | $0 | 1,029,500 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:30 pm | N/A 2035-01-01 | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 274,100 | $0 | 274,100 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:30 pm | N/A 2035-01-01 | ARS Pharmaceuticals Inc. | SPRY | Scott Kathleen D. Chief Financial Officer | 176,700 | $0 | 176,700 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:30 pm | N/A 2035-01-01 | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 152,300 | $0 | 152,300 (Direct) | View |
| 2024-12-13 Exercise | 2024-12-13 7:53 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 27,272 | $1.44 | 310,888 (Direct) | View |
| 2024-12-12 Exercise | 2024-12-13 7:53 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 117,333 | $0.84 | 310,888 (Direct) | View |
| 2024-12-12 Exercise | 2024-12-13 7:53 pm | N/A 2029-07-04 | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 144,605 | $0 | 310,888 (Direct) | View |
| 2024-12-11 Exercise | 2024-12-13 7:52 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Dorsey Brian Chief Operating Officer | 40,000 | $0.64 | 74,680 (Direct) | View |
| 2024-12-11 Exercise | 2024-12-13 7:52 pm | N/A 2028-11-28 | ARS Pharmaceuticals Inc. | SPRY | Dorsey Brian Chief Operating Officer | 40,000 | $0 | 74,680 (Direct) | View |
| 2024-12-10 Exercise | 2024-12-12 5:41 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 50,000 | $0.84 | 136,380 (Direct) | View |
| 2024-12-10 Exercise | 2024-12-12 5:41 pm | N/A 2029-07-04 | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 50,000 | $0 | 136,380 (Direct) | View |
| 2024-12-06 Exercise | 2024-12-09 5:43 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 13,789 | $1.44 | 13,050,073 (Direct) | View |
| 2024-12-06 Exercise | 2024-12-09 5:43 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 11,876 | $8.42 | 13,050,073 (Direct) | View |
| 2024-12-06 Exercise | 2024-12-09 5:43 pm | N/A 2031-12-13 | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 37,541 | $0 | 13,050,073 (Direct) | View |
| 2024-12-06 Exercise | 2024-12-09 5:25 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 13,789 | $1.44 | 13,050,073 (Indirect) | View |
| 2024-12-06 Exercise | 2024-12-09 5:25 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 11,876 | $8.42 | 13,050,073 (Direct) | View |
| 2024-12-06 Exercise | 2024-12-09 5:25 pm | N/A 2033-01-02 | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 37,541 | $0 | 13,050,073 (Direct) | View |
| 2024-12-04 Exercise | 2024-12-06 7:15 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 144,640 | $0.84 | 436,020 (Direct) | View |
| 2024-12-04 Exercise | 2024-12-06 7:15 pm | N/A 2029-07-04 | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 144,640 | $0 | 436,020 (Direct) | View |
| 2024-12-02 Exercise | 2024-12-04 9:45 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 90,000 | $0.84 | 334,280 (Direct) | View |
| 2024-12-02 Exercise | 2024-12-04 9:45 pm | N/A 2029-12-16 | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 90,000 | $0 | 334,280 (Direct) | View |
| 2024-12-02 Exercise | 2024-12-04 9:40 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 122,850 | $1.27 | 368,852 (Direct) | View |
| 2024-12-03 Exercise | 2024-12-04 9:40 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 77,150 | $3.15 | 368,852 (Direct) | View |
| 2024-12-02 Exercise | 2024-12-04 9:40 pm | N/A 2030-04-28 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 200,000 | $0 | 368,852 (Direct) | View |
| 2024-12-02 Exercise | 2024-12-04 9:40 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 10,000 | $1.5 | 1,181,152 (Direct) | View |
| 2024-12-02 Exercise | 2024-12-04 9:40 pm | N/A 2032-05-23 | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 10,000 | $0 | 1,181,152 (Direct) | View |
| 2024-10-16 Exercise | 2024-10-17 4:30 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Scott Kathleen D. Chief Financial Officer | 12,500 | $1.5 | 815,529 (Direct) | View |
| 2024-10-16 Exercise | 2024-10-17 4:30 pm | N/A 2032-02-29 | ARS Pharmaceuticals Inc. | SPRY | Scott Kathleen D. Chief Financial Officer | 12,500 | $0 | 815,529 (Direct) | View |
| 2024-09-18 Exercise | 2024-09-19 4:30 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 10,000 | $1.5 | 600,281 (Direct) | View |
| 2024-09-18 Exercise | 2024-09-19 4:30 pm | N/A 2032-05-23 | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 10,000 | $0 | 600,281 (Direct) | View |